ArticleScientific reports2025
Chitosan/ZnO nanohybrid as an efficacious compatibilizer for PLA/PBS blend suitable candidate for biodegradable packaging applications.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, chitosan-zinc oxide (CS-ZnO) nanohybrids were investigated as a new compatibilizer for biodegradable poly(lactic acid)/poly(butylene succinate) (PLA/PBS) blends. The novelty of this work lies in the synergistic effect arising from the hybridization of ZnO with chitosan, which enhances the interfacial compatibility between PLA and PBS and overcomes the limitations of pure ZnO, such as agglomeration and weak adhesion to the polymer matrix. PLA/PBS blends (80/20 wt%) were reinforced with different concentrations (0.1-0.5 wt%) of ZnO and CS-ZnO via solution casting. Mechanical testing showed that the addition of only 0.25 wt% of CS-ZnO improved the elongation at break by 50% and the tensile strength by 52% compared to pure ZnO. Morphological analysis using scanning electron microscopy (SEM) showed that the addition of only 0.25 wt% of CS-ZnO into PLA/PBS decreased the radius of PBS droplets from 423 nm to 349 nm, indicating improved compatibility between the PLA and PBS phases. This compatibility was further supported by rheological measurements, which showed an increased viscosity in the nano-hybrid-filled blend from 50 Pa.s to 110 Pa.s. Hydrolytic degradation tests, evaluated through mass loss over time, revealed accelerated degradation in CS-ZnO nanocomposites, because of increased hydrophilicity and interfacial areas. This study employed Density Functional Theory (DFT) with the semi-empirical PM6 method to estimate binding energies in binary and ternary systems, confirming experimental findings. Strong negative binding energies for PLA-ZnO and PBS-ZnO suggest high interfacial affinity, while PLA-CS showed weakly unfavorable interactions. The addition of ZnO to PLA-CS and PBS-CS systems resulted in favorable binding energies, emphasizing CS-ZnO hybrids' role in improving compatibility, stability, and bioactivity-controlled degradability of PLA/PBS-based nanocomposites, advancing sustainable materials for packaging and biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.